Bristol Myers Squibb Taps Chai Discovery for AI-Driven Antibody Design

Companies: Chai Discovery & Bristol Myers Squibb · Event Type: Research Collaboration · Modality: AI-Driven Antibody Design · Announcement Date: August 20, 2026 Summary Chai Discovery announced a research collaboration under which Bristol Myers Squibb will use Chai’s molecular-folding and generative-design models to support therapeutic-antibody…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *